These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8414198)

  • 1. Ubiquitin-reactive neurites in cerebral cortex of subjects with Huntington's chorea: a pathological correlate of dementia?
    Cammarata S; Caponnetto C; Tabaton M
    Neurosci Lett; 1993 Jun; 156(1-2):96-8. PubMed ID: 8414198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cortical neuritic pathology of Huntington's disease.
    Jackson M; Gentleman S; Lennox G; Ward L; Gray T; Randall K; Morrell K; Lowe J
    Neuropathol Appl Neurobiol; 1995 Feb; 21(1):18-26. PubMed ID: 7770116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
    DiFiglia M; Sapp E; Chase KO; Davies SW; Bates GP; Vonsattel JP; Aronin N
    Science; 1997 Sep; 277(5334):1990-3. PubMed ID: 9302293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontal lobe degeneration: novel ubiquitin-immunoreactive neurites within frontotemporal cortex.
    Tolnay M; Probst A
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):492-7. PubMed ID: 8745238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.
    Hedreen JC; Peyser CE; Folstein SE; Ross CA
    Neurosci Lett; 1991 Dec; 133(2):257-61. PubMed ID: 1840078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain.
    Maat-Schieman ML; Dorsman JC; Smoor MA; Siesling S; Van Duinen SG; Verschuuren JJ; den Dunnen JT; Van Ommen GJ; Roos RA
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):129-37. PubMed ID: 10029096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease.
    Nana AL; Kim EH; Thu DC; Oorschot DE; Tippett LJ; Hogg VM; Synek BJ; Roxburgh R; Waldvogel HJ; Faull RL
    J Huntingtons Dis; 2014; 3(1):45-64. PubMed ID: 25062764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects.
    Dickson DW; Wertkin A; Kress Y; Ksiezak-Reding H; Yen SH
    Lab Invest; 1990 Jul; 63(1):87-99. PubMed ID: 2165197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal, ubiquitinated cortical neurites in patients with diffuse Lewy body disease.
    Pellisé A; Roig C; Barraquer-Bordás LI; Ferrer I
    Neurosci Lett; 1996 Mar; 206(2-3):85-8. PubMed ID: 8710193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-immunohistochemical investigation of atypical Pick's disease without Pick bodies.
    Iseki E; Li F; Odawara T; Hino H; Suzuki K; Kosaka K; Akiyama H; Ikeda K; Kato M
    J Neurol Sci; 1998 Aug; 159(2):194-201. PubMed ID: 9741407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical and striatal neurone number in Huntington's disease.
    Heinsen H; Strik M; Bauer M; Luther K; Ulmar G; Gangnus D; Jungkunz G; Eisenmenger W; Götz M
    Acta Neuropathol; 1994; 88(4):320-33. PubMed ID: 7839825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for progression in frontal cortical pathology in late-stage Huntington's disease.
    Selemon LD; Rajkowska G; Goldman-Rakic PS
    J Comp Neurol; 2004 Jan; 468(2):190-204. PubMed ID: 14648679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom heterogeneity in Huntington's disease correlates with neuronal degeneration in the cerebral cortex.
    Mehrabi NF; Waldvogel HJ; Tippett LJ; Hogg VM; Synek BJ; Faull RL
    Neurobiol Dis; 2016 Dec; 96():67-74. PubMed ID: 27569581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of morphological features in Huntington's disease.
    Roos RA; Bots GT; Hermans J
    Acta Neurol Scand; 1986 Feb; 73(2):131-5. PubMed ID: 2939683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EEG in Huntington's chorea: a clinical and neuropathological study.
    Scott DF; Heathfield KW; Toone B; Margerison JH
    J Neurol Neurosurg Psychiatry; 1972 Feb; 35(1):97-102. PubMed ID: 4260288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
    Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid beta-protein deposition is present.
    Benzing WC; Mufson EJ; Armstrong DM
    Brain Res; 1993 Mar; 606(1):10-8. PubMed ID: 8096426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.
    de la Monte SM; Vonsattel JP; Richardson EP
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):516-25. PubMed ID: 2971785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degeneration of pyramidal projection neurons in Huntington's disease cortex.
    Cudkowicz M; Kowall NW
    Ann Neurol; 1990 Feb; 27(2):200-4. PubMed ID: 2138444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.